Methamphetamine Response Act: A Historical Overview

The Methamphetamine Response Act was signed into law on March 14, 2022, by President Biden. The bill, which was introduced by Senators Chuck Grassley and Dianne Feinstein, directs the Office of National Drug Control Policy (ONDCP) to implement a plan to address the rising use of methamphetamine. The new law passed with broad bipartisan support and aims to help law enforcement better respond to the evolving tactics of drug traffickers and ensure federal partners continue to prioritize a response to the meth crisis. The Act designates methamphetamine as an emerging drug threat and requires the ONDCP to develop and implement a national emerging threats response plan within 90 days of enactment.

The Methamphetamine Response Act of 2021

Background

Methamphetamine is a highly addictive stimulant that has been classified as a Schedule II substance by the Drug Enforcement Administration (DEA) in the United States. While methamphetamine has been a long-standing issue, recent years have seen a spike in overdose rates as traffickers find ways to increase its potency and widen its distribution.

Legislative History

Provisions of the Act

• Develop and implement a national emerging threats response plan specific to methamphetamine within 90 days of the enactment of the Act.
• Update the plan annually, including assessments of the methamphetamine threat, evidence-based prevention and treatment programs, and law enforcement programs.
• Establish short- and long-term goals, including those focused on supply and demand reduction and expanding access to effective treatment and prevention programs.
• Determine the level of funding required to implement the plan and develop an implementation strategy, including media campaign goals and objectives.

Impact

Methamphetamine as an emerging drug threat

The Methamphetamine Response Act, which was signed into law in 2022, designates methamphetamine as an emerging drug threat. The act was introduced by Sens. Chuck Grassley (R-Iowa) and Dianne Feinstein (D-Calif.) and passed with broad bipartisan support.

Methamphetamine is a highly addictive synthetic stimulant that can be smoked, snorted, injected, or administered orally or rectally. It is commonly referred to as "crystal meth," "tina," or "ice." The drug has high addiction potential and can cause serious negative health effects, including paranoia, anxiety, rapid heart rate, irregular heartbeat, stroke, and even death. Long-term use may lead to insomnia, memory loss, substance use disorder, and other health problems.

Methamphetamine poses a significant threat to the United States, with increasing availability, production, and distribution nationwide. According to state and local law enforcement agencies, the threat associated with methamphetamine trafficking and abuse has increased sharply since 2002 and now exceeds that of any other drug. The National Drug Intelligence Center's National Drug Threat Survey data show that the percentage of state and local law enforcement agencies identifying methamphetamine as the greatest drug threat in their areas increased from 31.0% in 2002 to 39.6% in 2004.

The production and distribution of methamphetamine have increased significantly due to the establishment of large-scale production operations in Mexico, a major supplier to users nationwide. This has led to greater availability and lower prices, making it more accessible to users. In 2024, approximately 2.5 million people in the United States reported using methamphetamine in the past 12 months.

The abuse of methamphetamine is also linked to various social issues. Child neglect and abuse are common within families where parents or caregivers produce or use the drug. According to the Department of Justice's Office for Victims of Crime, children living with methamphetamine users are more likely to experience neglect, physical abuse, sexual abuse, and mental abuse. The drug's availability and affordability, coupled with its highly addictive nature, make it a growing concern in the United States.

The Methamphetamine Response Act aims to address this emerging threat by directing the Office of National Drug Control Policy to implement a response plan. This plan will include an assessment of the methamphetamine threat, evidence-based prevention and treatment programs, short- and long-term goals, performance measures, funding requirements, and a media campaign strategy.

The role of the Office of National Drug Control Policy

The Methamphetamine Response Act of 2021 was signed into law on March 14, 2022. The Act designates methamphetamine as an emerging drug threat and outlines the role of the Office of National Drug Control Policy (ONDCP) in addressing this issue.

The ONDCP, a component of the Executive Office of the President, plays a crucial role in coordinating and implementing the nation's drug policy. The Director of the ONDCP, colloquially known as the drug czar, leads the office and is responsible for evaluating, coordinating, and overseeing both international and domestic anti-drug efforts of executive branch agencies. The Director advises the President on matters pertaining to federal agencies' organization, management, budgeting, and personnel as they relate to anti-drug efforts.

In the context of the Methamphetamine Response Act, the ONDCP is tasked with implementing a methamphetamine response plan. Specifically, the Act requires the Director of the ONDCP to establish and implement an Emerging Threat Response Plan specific to methamphetamine within 90 days of the Act's enactment. This plan must be updated annually and include the following components:

• An assessment of the methamphetamine threat, including its availability and demand
• Evaluation of evidence-based prevention, treatment, and law enforcement programs
• Short- and long-term goals focused on supply and demand reduction, as well as expanding treatment and prevention programs
• Performance measures related to the plan's goals
• Funding requirements for implementing the plan
• A media campaign strategy, goals, and objectives

The ONDCP coordinates across 19 federal agencies and oversees a significant budget to address addiction and the overdose epidemic. The office also provides additional funding to communities through programs such as the High-Intensity Drug Trafficking Areas Program and the Drug-Free Communities Program.

The impact of the Act on law enforcement

The Methamphetamine Response Act of 2021 was signed into law on March 14, 2022, by President Biden. The Act designates methamphetamine as an emerging drug threat and outlines a plan to address the rising use and overdose rates of the drug.

Impact on Law Enforcement

The Methamphetamine Response Act has had a significant impact on law enforcement, providing them with new tools and resources to combat the illegal production, distribution, and use of methamphetamine. Firstly, the Act has increased interagency collaboration, as it mandates that the Director of the Office of National Drug Control Policy (ONDCP) establish and implement an Emerging Threat Response Plan specific to methamphetamine. This plan involves coordination between various government agencies, including law enforcement, to address the complex and evolving nature of the methamphetamine threat.

Secondly, the Act has enhanced law enforcement's ability to identify and target methamphetamine-related crimes by requiring the ONDCP to develop and make public a national emerging threats response plan. This plan includes an assessment of the current methamphetamine threat, taking into account its availability, demand, and evidence-based prevention and treatment programs. By having access to this comprehensive information, law enforcement agencies can better allocate resources, develop targeted strategies, and improve their ability to detect and disrupt methamphetamine trafficking networks.

The Act also emphasizes the importance of reducing the supply of and demand for methamphetamine. To achieve this, law enforcement agencies are now encouraged to collaborate with public health officials and community organizations to develop short- and long-term goals. These goals may include expanding the availability and effectiveness of treatment and prevention programs, as well as implementing media campaigns to raise awareness about the dangers of methamphetamine use.

Furthermore, the Act has likely led to an increase in funding for law enforcement agencies to specifically target methamphetamine-related crimes. The ONDCP's plan includes a requirement to outline the level of funding needed to implement the response strategy, recognizing the importance of adequate resources in tackling the methamphetamine crisis. This additional funding can be used to enhance law enforcement's capabilities, improve training, and acquire advanced technologies to detect and interdict methamphetamine production and distribution networks.

Overall, the Methamphetamine Response Act has empowered law enforcement agencies to better respond to the challenges posed by methamphetamine. By providing a comprehensive framework, promoting interagency collaboration, and allocating resources, the Act has equipped law enforcement with the necessary tools to address the evolving tactics of drug traffickers and make a significant impact in reducing the harm caused by methamphetamine in communities across the nation.

International perspectives on methamphetamine legislation

The Methamphetamine Response Act was passed into law in March 2022. It designates methamphetamine as an emerging drug threat and requires the Office of National Drug Control Policy to implement a plan to address the rising use of methamphetamine.

Frequently asked questions